Healthcare Outcomes Performance Company (HOPCo) has announced the appointment of Alan Hoops to its board of directors.
Healthcare Outcomes Performance Company Appoints Alan Hoops to BOD
1 min read Premium comments
Secondary#healthcareoutcomesperformancecompany#alanhoops
HOPCo is a physician-operated healthcare management company. It uses proprietary information technology platforms and standardized clinical protocols to improve the patient care experience. Its team of orthopedic and musculoskeletal (MSK) experts focuses on reducing costs and improving outcomes through every aspect of the care process.
OTW spoke with Hoops about his new appointment. Hoops told OTW, “I’ve been interested in diagnoses and conditions that lend themselves to more rational approaches. MSK is one of those categories and HOPCo is clearly ahead of the pack. I’m delighted to become a part of the team.”
The former chairman and chief executive officer of PacifiCare Health Systems, Inc., Hoops has more than 30 years of experience in the healthcare industry. His background includes both healthcare and managed care.
While at PacifiCare, Hoops led the company’s expansion from California into eight other states. Under his leadership the company’s revenue quadrupled and it made multiple acquisitions. Notably, during his time with PacifiCare, it launched the Secure Horizons program. The program became the nation’s largest Medicare health maintenance organization (HMO) health plan.
Since leaving PacifiCare in 2000, Hoops has continued to lead notable companies and has been on the board of at least six emerging companies. In 2006, he led the purchase of CareMore Health Plan. After the purchase he served as CareMore’s chief executive officer from 2006 to 2011. After leaving CareMore, Hoops joined HealthEssentials, LLC, serving as its executive chairman from 2012 to 2017. He has not slowed down and currently serves on the board of CorVel Corporation.
HOPCo Chairman David Jacofsky, M.D., commented on Hoops’ experience saying, “Alan’s 30 years of experience in building best in class companies in the managed care industry and his recognition of our mission to improve value will be a great asset for HOPCo.”
Dr. Jacofsky continued, “We are confident that Alan will help drive the expansion of true population health and alternative payment models in musculoskeletal care across the country.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.